Literature DB >> 12183523

Comparison of host resistance to primary and secondary Listeria monocytogenes infections in mice by intranasal and intravenous routes.

Mayuko Mizuki1, Akio Nakane, Kenji Sekikawa, Yoh-ich Tagawa, Yoichiro Iwakura.   

Abstract

There have been no studies on the susceptibility and host immune responses to an intranasal infection with Listeria monocytogenes. In this study, we compared the susceptibilities and cytokine responses between intranasal and intravenous infections with L. monocytogenes in mice. Moreover, we compared efficiency of acquisition of host resistance to L. monocytogenes infection between intranasally and intravenously immunized mice because an intranasal immunization of vaccines is reportedly available for induction of adaptive immunity against various infectious pathogens. The susceptibility to an intranasal infection with L. monocytogenes was markedly lower than that to the intravenous infection. The bacterial growth in the lungs, spleens, and livers was substantially similar between intranasally and intravenously infected mice. Titers of endogenous gamma interferon (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha) in the spleens, livers, and lungs were parallel to bacterial numbers in each organ of mice during intranasal infection and intravenous infection. IFN-gamma-deficient mice and TNF-alpha-deficient mice were highly susceptible to intranasal infection as well as intravenous infection. Susceptibilities to intranasal and intravenous L. monocytogenes infection were the same in these cytokine-deficient mice. These results suggest that both IFN-gamma and TNF-alpha play critical roles in host resistance to intranasal L. monocytogenes infection as well as the intravenous infection. Acquisition of host resistance to intravenous and intranasal L. monocytogenes infection was induced in intranasally immunized mice as well as intravenously immunized mice, suggesting that intranasal immunization is effective for prevention of a systemic infection with L. monocytogenes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12183523      PMCID: PMC128264          DOI: 10.1128/IAI.70.9.4805-4811.2002

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  37 in total

1.  Intranasal administration of synthetic recombinant peptide-based vaccine protects mice from infection by Schistosoma mansoni.

Authors:  T Ben-Yedidia; R Tarrab-Hazdai; D Schechtman; R Arnon
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Intranasal immunization with heat-inactivated Streptococcus pneumoniae protects mice against systemic pneumococcal infection.

Authors:  B K Hvalbye; I S Aaberge; M Løvik; B Haneberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

3.  Failure of germinal center formation and impairment of response to endotoxin in tumor necrosis factor alpha-deficient mice.

Authors:  T Taniguchi; M Takata; A Ikeda; E Momotani; K Sekikawa
Journal:  Lab Invest       Date:  1997-12       Impact factor: 5.662

4.  Effects of liver-derived dendritic cell progenitors on Th1- and Th2-like cytokine responses in vitro and in vivo.

Authors:  A Khanna; A E Morelli; C Zhong; T Takayama; L Lu; A W Thomson
Journal:  J Immunol       Date:  2000-02-01       Impact factor: 5.422

5.  Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen.

Authors:  O Akbari; R H DeKruyff; D T Umetsu
Journal:  Nat Immunol       Date:  2001-08       Impact factor: 25.606

6.  Incidence of Listeria monocytogenes in nature.

Authors:  J Weis; H P Seeliger
Journal:  Appl Microbiol       Date:  1975-07

7.  Epidemic listeriosis--evidence for transmission by food.

Authors:  W F Schlech; P M Lavigne; R A Bortolussi; A C Allen; E V Haldane; A J Wort; A W Hightower; S E Johnson; S H King; E S Nicholls; C V Broome
Journal:  N Engl J Med       Date:  1983-01-27       Impact factor: 91.245

8.  Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection.

Authors:  B T Edelson; P Cossart; E R Unanue
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

9.  Systemic dissemination by intrarectal infection with Listeria monocytogenes in mice.

Authors:  S Nishikawa; M Hirasue; T Miura; K Yamada; S Sasaki; A Nakane
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

10.  Impaired immune and acute-phase responses in interleukin-6-deficient mice.

Authors:  M Kopf; H Baumann; G Freer; M Freudenberg; M Lamers; T Kishimoto; R Zinkernagel; H Bluethmann; G Köhler
Journal:  Nature       Date:  1994-03-24       Impact factor: 49.962

View more
  10 in total

1.  Intranasal vaccination with the recombinant Listeria monocytogenes ΔactA prfA* mutant elicits robust systemic and pulmonary cellular responses and secretory mucosal IgA.

Authors:  Jin Qiu; Lin Yan; Jianbo Chen; Crystal Y Chen; Ling Shen; Norman L Letvin; Barton F Haynes; Nancy Freitag; Lijun Rong; James T Frencher; Dan Huang; Xunming Wang; Zheng W Chen
Journal:  Clin Vaccine Immunol       Date:  2011-01-26

Review 2.  Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?

Authors:  Theodoros Kelesidis; Amandeep Salhotra; Jorge Fleisher; Daniel Z Uslan
Journal:  J Infect       Date:  2010-02-20       Impact factor: 6.072

3.  Role of tumor necrosis factor alpha in development of immunity against Cryptosporidium parvum infection.

Authors:  I-Sarah Lean; Sonia Lacroix-Lamandé; Fabrice Laurent; Vincent McDonald
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

4.  The probacterial effect of type I interferon signaling requires its own negative regulator USP18.

Authors:  Namir Shaabani; Nadine Honke; Nhan Nguyen; Zhe Huang; Kei-Ichiro Arimoto; Daniel Lazar; Taylor K Loe; Karl S Lang; Marco Prinz; Klaus-Peter Knobeloch; Dong-Er Zhang; John R Teijaro
Journal:  Sci Immunol       Date:  2018-09-28

5.  Mouse peptidoglycan recognition protein PGLYRP-1 plays a role in the host innate immune response against Listeria monocytogenes infection.

Authors:  Arihiro Osanai; Hiroshi Sashinami; Krisana Asano; Sheng-Jun Li; Dong-Liang Hu; Akio Nakane
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

6.  Adipose Tissue-Derived Mesenchymal Stem Cells Attenuate Staphylococcal Enterotoxin A-Induced Toxic Shock.

Authors:  Krisana Asano; Sayuri Yoshimura; Akio Nakane
Journal:  Infect Immun       Date:  2015-06-22       Impact factor: 3.441

7.  The bradykinin B2 receptor in the early immune response against Listeria infection.

Authors:  Wendy E Kaman; Arthur F W M Wolterink; Michael Bader; Linda C L Boele; Desiree van der Kleij
Journal:  Med Microbiol Immunol       Date:  2008-09-23       Impact factor: 3.402

8.  Listeria meningitis complicating infliximab treatment for Crohn's disease.

Authors:  Geoffrey Williams; Asad A Khan; Franzjosef Schweiger
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-09       Impact factor: 2.471

9.  Nutritional route affects ERK phosphorylation and cytokine production in hepatic mononuclear cells.

Authors:  Tomoyuki Moriya; Kazuhiko Fukatsu; Yoshinori Maeshima; Fumie Ikezawa; Chikara Ueno; Woodae Kang; Eiji Takakayama; Daizoh Saitoh; Hidetaka Mochizuki; Masaru Miyazaki
Journal:  Ann Surg       Date:  2007-04       Impact factor: 12.969

10.  Listeria ivanovii Infection in Mice: Restricted to the Liver and Lung with Limited Replication in the Spleen.

Authors:  Mengying Zhou; Mingjuan Jiang; Chenyan Ren; Sijing Liu; Qikang Pu; Howard Goldfine; Hao Shen; Chuan Wang
Journal:  Front Microbiol       Date:  2016-06-07       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.